LARSEN MARSHALL O
SEC CIK 1024382 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BDX | Becton Dickinson | Dir | 28.9K | — | — | 2 | 2022-01-25 | 2023-01-24 |
Most active insiders at BDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Polen Thomas E Jr | COB, CEO, Pres, Dir | — | $1.17M |
| 2 | Garrison Michael David | EVP, Pres Med.Essntl, BioPharm | — | $784.2K |
| 3 | Goette Roland | EVP, Pres, EMEA | — | $440.9K |
| 4 | SCOTT BERTRAM L | Dir | — | $212.3K |
| 5 | Feld Michael | EVP, Pres, Life Sciences | — | $167.4K |
| 6 | Menziuso Peter | EVP, Pres, BDI | — | — |
| 7 | Roque Vitor | Interim CFO | — | — |
| 8 | Spikner Pamela L. | SVPController, Chief Acct Off | — | — |
| 9 | Shan David | EVP, Chief ISC Off | — | — |
| 10 | Waldstreicher Joanne | Dir | — | — |
LARSEN MARSHALL O made no open-market trades at BDX in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-26 | 2023-01-24 | BDX | Becton Dickinson | LARSEN MARSHALL O | Dir | A - Grant | $0.00 | +848 | 28.9K | +3% | $0 | |
| 2022-01-27 | 2022-01-25 | BDX | Becton Dickinson | LARSEN MARSHALL O | Dir | A - Grant | $0.00 | +820 | 23.8K | +4% | $0 |
Purchase Sale Sale after option exercise All abbreviations